Literature DB >> 18671658

Vascular disease and cognitive impairment.

Christiane Reitz, José A Luchsinger, Richard Mayeux.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18671658      PMCID： PMC2697122          DOI： 10.1586/14737175.8.8.1171

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  50 in total

1.  The origins of Alzheimer disease: a is for amyloid.

Authors:  D J Selkoe
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

2.  Diabetes mellitus and the risk of dementia: The Rotterdam Study.

Authors:  A Ott; R P Stolk; F van Harskamp; H A Pols; A Hofman; M M Breteler
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease.

Authors:  G Stennis Watson; Tanja Bernhardt; Mark A Reger; Brenna A Cholerton; Laura D Baker; Elaine R Peskind; Sanjay Asthana; Stephen R Plymate; Lutz Frölich; Suzanne Craft
Journal:  Neurobiol Aging       Date:  2006-01       Impact factor: 4.673

4.  Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Authors:  M Di Bari; M Pahor; L V Franse; R I Shorr; J Y Wan; L Ferrucci; G W Somes; W B Applegate
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

Review 5.  The pathology of ischemic-vascular dementia: an update.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

6.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

Authors:  Rita Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

7.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.

Authors:  M Kivipelto; E L Helkala; M P Laakso; T Hänninen; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen
Journal:  BMJ       Date:  2001-06-16

8.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

9.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.

Authors:  G Fein; V Di Sclafani; J Tanabe; V Cardenas; M W Weiner; W J Jagust; B R Reed; D Norman; N Schuff; L Kusdra; T Greenfield; H Chui
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

10.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

Authors:  J A Luchsinger; M X Tang; Y Stern; S Shea; R Mayeux
Journal:  Am J Epidemiol       Date:  2001-10-01       Impact factor: 4.897
View more
  4 in total

1.  Risk of Alzheimer's disease incidence attributable to vascular disease in the population.

Authors:  Hiroko H Dodge; Chung-Chou H Chang; Ilyas M Kamboh; Mary Ganguli
Journal:  Alzheimers Dement       Date:  2011-05       Impact factor: 21.566

2.  Nitric oxide synthase inhibition in healthy adults reduces regional and total cerebral macrovascular blood flow and microvascular perfusion.

Authors:  Katrina J Carter; Aaron T Ward; J Mikhail Kellawan; Marlowe W Eldridge; Awni Al-Subu; Benjamin J Walker; Jeffrey W Lee; Oliver Wieben; William G Schrage
Journal:  J Physiol       Date:  2021-10-13       Impact factor: 6.228

3.  Incremental Doses of Nitrate-Rich Beetroot Juice Do Not Modify Cognitive Function and Cerebral Blood Flow in Overweight and Obese Older Adults: A 13-Week Pilot Randomised Clinical Trial.

Authors:  Abrar M Babateen; Oliver M Shannon; Gerard M O'Brien; Edward Okello; Ellen Smith; Dilara Olgacer; Christina Koehl; William Fostier; Emma Wightman; David Kennedy; John C Mathers; Mario Siervo
Journal:  Nutrients       Date:  2022-03-02       Impact factor: 5.717

4.  Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.

Authors:  Antonino Tuttolomondo; Salvatore Petta; Alessandra Casuccio; Carlo Maida; Vittoriano Della Corte; Mario Daidone; Domenico Di Raimondo; Rosaria Pecoraro; Roberto Fonte; Anna Cirrincione; Rita Zafonte; Daniela Cabibi; Calogero Cammà; Vito Di Marco; Anna Licata; Franco Magliozzo; Giulio Marchesini; Giovanni Merlino; Antonio Craxì; Antonio Pinto
Journal:  Cardiovasc Diabetol       Date:  2018-02-16       Impact factor: 9.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.